1. Home
  2. CCTG vs QNRX Comparison

CCTG vs QNRX Comparison

Compare CCTG & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCSC Technology International Holdings Limited

CCTG

CCSC Technology International Holdings Limited

N/A

Current Price

$0.29

Market Cap

8.9M

Sector

N/A

ML Signal

N/A

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

N/A

Current Price

$4.53

Market Cap

9.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCTG
QNRX
Founded
1993
2018
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
9.2M
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
CCTG
QNRX
Price
$0.29
$4.53
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $20.38
AVG Volume (30 Days)
★ 373.3K
22.7K
Earning Date
07-17-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.08
$3.25
52 Week High
$5.64
$23.50

Technical Indicators

Market Signals
Indicator
CCTG
QNRX
Relative Strength Index (RSI) 26.22 43.71
Support Level N/A $4.03
Resistance Level $0.54 $4.50
Average True Range (ATR) 0.05 0.24
MACD -0.00 0.09
Stochastic Oscillator 44.55 69.57

Price Performance

Historical Comparison
CCTG
QNRX

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd, through its direct wholly-owned subsidiaries, is principally engaged in the manufacturing and sale of interconnect products, including connectors, cables and wire harnesses. The company produces both original equipment manufacturer (OEM) and original design manufacturer (ODM) interconnect products for manufacturing companies that produce end products, as well as for electronic manufacturing services (EMS) companies. The majority of the company's revenue is derived from the sale of Cable and wire harnesses, and Connectors. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: